BRIX1 Promotes Hepatocellular Carcinoma Progression via the MAPK/ERK Pathway and Serves as a Prognostic Biomarker
Xianzhu Pan, Xiaoqing Wang, Yuanqin Zhou
This study identifies BRIX1 as a promoter of hepatocellular carcinoma progression through the MAPK/ERK pathway and shows its potential as a prognostic biomarker.
bioRxiv · Aug 31, 2026 · PreprintCancer Biology